FERRARI, GIULIANA
 Distribuzione geografica
Continente #
AS - Asia 2.726
EU - Europa 2.676
NA - Nord America 1.724
SA - Sud America 738
AF - Africa 63
OC - Oceania 5
Totale 7.932
Nazione #
US - Stati Uniti d'America 1.639
RU - Federazione Russa 1.590
CN - Cina 1.012
SG - Singapore 881
BR - Brasile 607
SE - Svezia 426
HK - Hong Kong 314
VN - Vietnam 252
IT - Italia 199
FR - Francia 128
DE - Germania 96
GB - Regno Unito 62
AR - Argentina 55
BD - Bangladesh 55
IN - India 49
CA - Canada 42
FI - Finlandia 33
PL - Polonia 33
JP - Giappone 31
MX - Messico 27
ID - Indonesia 25
AT - Austria 23
EC - Ecuador 21
IE - Irlanda 19
ZA - Sudafrica 19
ES - Italia 18
NL - Olanda 18
TR - Turchia 16
IQ - Iraq 14
CL - Cile 11
CO - Colombia 11
UA - Ucraina 11
PK - Pakistan 10
VE - Venezuela 10
MA - Marocco 9
PE - Perù 9
TN - Tunisia 9
PY - Paraguay 8
KG - Kirghizistan 6
UZ - Uzbekistan 6
CH - Svizzera 5
KE - Kenya 5
MY - Malesia 5
PH - Filippine 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
IL - Israele 4
JM - Giamaica 4
NP - Nepal 4
BH - Bahrain 3
JO - Giordania 3
KR - Corea 3
PA - Panama 3
QA - Qatar 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
HN - Honduras 2
LB - Libano 2
LT - Lituania 2
NI - Nicaragua 2
PS - Palestinian Territory 2
PT - Portogallo 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AO - Angola 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
CZ - Repubblica Ceca 1
DM - Dominica 1
GA - Gabon 1
GR - Grecia 1
IR - Iran 1
KZ - Kazakistan 1
LY - Libia 1
MD - Moldavia 1
ML - Mali 1
MT - Malta 1
NA - Namibia 1
NO - Norvegia 1
NR - Nauru 1
OM - Oman 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
SR - Suriname 1
TW - Taiwan 1
Totale 7.932
Città #
Moscow 386
Singapore 358
Hong Kong 312
Ashburn 272
San Jose 237
Shanghai 197
Dallas 181
Beijing 142
Hefei 129
Lawrence 112
Princeton 112
Lauterbourg 111
Ho Chi Minh City 97
New York 69
Milan 67
Los Angeles 53
Hanoi 51
São Paulo 41
Boardman 32
Warsaw 26
Helsinki 25
Tokyo 24
Rio de Janeiro 21
Brooklyn 20
Nuremberg 20
Dublin 19
Guangzhou 19
Orem 19
Santa Clara 19
Poplar 16
Haiphong 15
Belo Horizonte 14
Munich 14
Vienna 14
Cesano Boscone 13
Johannesburg 13
Pune 13
Rome 13
Da Nang 12
Frankfurt am Main 12
Ankara 11
Chennai 11
London 11
Houston 10
Phoenix 10
Salvador 10
San Francisco 10
Shenzhen 10
Stockholm 10
Xi'an 10
Brasília 9
Seattle 9
Tianjin 9
Assago 8
Atlanta 8
Denver 8
Dhaka 8
Montreal 8
Campinas 7
Council Bluffs 7
Lima 7
Manchester 7
Mexico City 7
Mumbai 7
Nova Iguaçu 7
Porto Alegre 7
Quito 7
Thái Bình 7
Toronto 7
Wuxi 7
Amsterdam 6
Bishkek 6
Buffalo 6
Hangzhou 6
New Delhi 6
Reston 6
Tashkent 6
Tunis 6
Turin 6
Turku 6
Washington 6
Aracaju 5
Boston 5
Caracas 5
Caxias do Sul 5
Changsha 5
Chicago 5
Goiânia 5
Guarulhos 5
Itajaí 5
Lahore 5
Santo André 5
The Dalles 5
Thái Nguyên 5
Anápolis 4
Asunción 4
Baghdad 4
Barcelona 4
Barnet 4
Betim 4
Totale 3.729
Nome #
Transfer of the HSV-tk gene into donor peripheral blood lymphocytes for in vivo modulation of donor anti-tumor immunity after allogeneic bone marrow transplantation 131
Long-term lineage commitment in haematopoietic stem cell gene therapy 127
Bone marrow as source of hematopoietic stem cells for human gene therapy of beta thalassemia 115
A clinical protocol for transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA deficient SCID 113
Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity 111
A human PBL immunodeficient mouse model for in vivo preclinical studies of human gene therapy. 110
Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent β-thalassemia 107
Bone marrow as an alternative site for islet transplantation 107
Correcting b-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity 107
NCOA4-mediated ferritinophagy in macrophages is crucial to sustain erythropoiesis in mice 106
Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells 101
A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease 101
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets 96
Targeting the Hematopoietic Stem Cell Niche in β-Thalassemia and Sickle Cell Disease 93
Bone marrow as an alternative site for islet transplantation 91
A Highly conserved SOX6 double binding site mediates SOX6 gene downregulation in erythroid cells 90
Bone marrow-derived hematopoietic cells undergo myogenic differentiation following a Pax-7 independent pathway 89
Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) β-thalassemia mutation 88
A retroviral vector containing a muscle-specific enhancer drives gene expression only in differentiated muscle fibers 88
Correction of ß-thalassemia major by gene transfer in hematopoietic progenitors of pediatric patients 87
Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapy 86
Cell-surface marking of CD(34+)-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer 84
An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency 84
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy 82
Characterization of Papilloma virus polypeptides from bovine cutaneous fibropapillomas 79
A non-producer interfering HIV-1 provirus can be transduced through a MLV-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus 79
Gene therapy using haematopoietic stem and progenitor cells 79
Bone marrow-derived stem cells repopulate glomerular and tubular kidney components - Effect of hyperglycemia 77
Clinical protocol: transfer of the ADA gene into bone marrow cells and peripheral blood lymphocytes for the treatment of patients affected by ADA-deficient SCID 73
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia 72
An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4 72
Aberrant, noninfectious HIV-1 particles are released by chronically infected human T cells transduced with a retroviral vector expressing an interfering HIV-1 variant 71
In vivo and in vitro models for the analysis of retroviral vector mediated expression of human ADA in ADA deficient cells from patients affected by severe combined immunodeficiency. 71
Terapia genica e malattia ereditaria 70
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 70
MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27 68
Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next-generation human artificial chromosomes for Duchenne muscular dystrophy 67
Safety of retroviral gene marking with a truncated NGF receptor 65
Muscle regeneration by bone marrow-derived myogenic progenitors 64
Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to Plerixafor alone 64
Stem cell plasticity: time for a reappraisal? 63
Pancreatic islets recruit mesenchymal stem cells by release of chemokines 63
Retroviral vector gene-transfer into donor peripheral-blood lymphocytes for in-vitro selection and in-vivo immunomodulation of donor antitumor immunity after allo-BMT 62
Gene-transfer into peripheral-blood lymphocytes for in-vivo immunomodulation of donor antitumor immunity in a patient affected by EBV-induced lymphoma 62
Retroviral heterogeneity in mouse lymphomas 62
Transient decrease of serum iron after acute erythropoietin treatment contributes to hepcidin inhibition by ERFE in mice 62
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia 62
Clonal analysis of stably transduced human epidermal stem cells in culture 62
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 62
Down-regulation of SPARC/osteonectin/BM-40 expression in methylcholanthrene-induced fibrosarcomas and in Kirsten-MSV transformed fibroblasts 61
Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment 61
Myogenic conversion of mammalian fibroblasts induced by differentiating muscle cells 61
The second transferrin receptor regulates red blood cell production in mice 60
Selective engraftment of genetically modified hematopoietic stem cells by a truncated erythropoietin receptor 60
Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA- Immunodeficient Patients 60
Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans 59
Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells 59
Protein kinase a-mediated synapsin I phosphorylation is a central modulator of Ca2+-dependent synaptic activity 59
Transfer of the ADA gene into human ADA-deficient T Lymphocytes reconstitutes specific immune functions 59
Gene Therapy Approaches to Hemoglobinopathies 59
Terapia Genica 58
Conditioning Regimens in Long-Term Pre-Clinical Studies to Support Development of Ex Vivo Gene Therapy: Review of Nonproliferative and Proliferative Changes 58
Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia 58
Imbalanced TGFβ signalling and autophagy drive erythroid priming of hematopoietic stem cells in β-thalassemia 58
Failure to correct murine muscular dystrophy 57
Strain polymorphism and tentative mapping of mouse ornithine decarboxylase 57
TRANSFER OF THE HSV-TK GENE INTO DONOR PERIPHERAL-BLOOD LYMPHOCYTES FOR IN-VIVO IMMUNOMODULATION OF DONOR ANTITUMOR IMMUNITY AFTER ALLO-BMT 57
In vivo and in vitro models for analysis of retroviral vector mediated expression of human ADA in ADA deficient cells from patients affected by severe combined immunodeficiency 56
Transcription Factor Binding Sites Are Genetic Determinant of Retroviral Integration in the Human Genome 56
Hypomorhic mutation of the TALE gene Prep1 (pKnox1) causes a major reduction of Pbx and Meis proteins and a pleiotropic embryonic phenotype 56
Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells 55
Transcription factor binding sites as genetic determinants of retroviral integration in the human genome 55
Reversible Immortalization of Human Myogenic Cells by Site-Specific Excision of a Retrovirally Transferred Oncogene 55
Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement 55
Gene therapy for beta thalassemia: preclinical studies on human cells 55
Transcript imaging of human T helper cell development using oligonucleotide arrays 54
The homeodomain transcription factor Prep1 (pKnox1) is required for hematopoietic stem and progenitor cell activity 54
Retroviral vectors for human gene therapy 54
Towards the correction of the genetic defect in corneal keratinocytes from patients with macular corneal dystrophy type II 53
Ly-5.185 molecule is associated with thymic maturation of lymphocytes but not with their cytotoxic activity 52
Sox6 enhances erythroid differentiation in human erythroid progenitors 52
Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement 51
The GATA1-HS2 Enhancer allows persistent and position-independent expression of ß-globin transgene 51
Deletion of a negatively acting sequence in a chimeric GATA-1 enchancer-LTR greatly increases retroviral-mediated erythroid expression 51
Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function 51
Persistent and Position Independent Transgene Expression in Erythroid Cells Transduced 51
Preclinical Assessment of a Gene Therapy Approach to beta-Thalassemia 51
Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo 50
Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression into muscle fibers in vivo 50
Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts 50
gag, vif, and nef genes contribute to the homologous viral interference induced by a nonproducer human immunodeficiency virus type 1 (HIV-1) variant: identification of novel HIV-1-inhibiting viral protein mutants 50
T-cell receptor genes in tassel-eared squirrels (Sciurus aberti). I. Genetic polymorhism and divergence in the Abert and Kaibab subspecies 49
Vector design influences retroviral integration in human hematopoietic cells 49
Mesenchymal Cells Appearing in Pancreatic Tissue Culture Are Bone Marrow-Derived Stem Cells With the Capacity to Improve Transplanted Islet Function 49
The influence of vector design on integration site selection by gamma-retroviral and lentiviral vectors 49
Gene transfer into human primary myogenic cells. 49
In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of beta-thalassemia 49
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermiolysis bullosa 49
Retroviral vectors for human gene therapy 49
Phosphorylation of synapsin I by cAMP-dependent protein kinase controls synaptic vesicle dynamics in developing neurons. 48
Totale 6.864
Categoria #
all - tutte 57.255
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.255


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022112 0 0 0 43 0 2 1 51 4 5 1 5
2022/2023685 253 169 45 5 2 99 25 52 17 9 6 3
2023/2024369 10 20 30 104 15 45 11 5 0 7 19 103
2024/20251.663 218 42 16 62 48 142 295 177 261 171 105 126
2025/20265.189 409 378 351 804 405 134 424 368 1.411 284 121 100
Totale 8.070